Nov 1, 2019
Executive Editor Michael Roy speaks with Yasmin Hurd, Ph.D.,
about her research on the
potential of cannabidiol (CBD) to reduce cue-induced craving
and anxiety, two critical features of addiction that often
contribute to relapse and continued drug use, in drug-abstinent
individuals with heroin use disorder.
- What has past research with CBD shown in terms of its function
as a treatment for mental illness? [2:29]
- Why the present study examined the potential of CBD to moderate
craving and anxiety, and how these reactions were triggered among
- How did the study team decide to evaluate CBD at two different
- Main findings of the study [7:42]
- Discussion of secondary outcomes and adverse events [9:02]
- Take-home messages for mental health professionals and the
general public [11:37]
- Thoughts on how the medical use of CBD will fit in to the
broader trend of the relaxation of marijuana laws throughout the
United States [13:28]
Be sure to let your colleagues know about the podcast, and
please rate and review it on Apple Podcasts, Google Play, Stitcher,
Spotify, or wherever you listen to it.
Listen to other podcasts
produced by the American Psychiatric Association.
Browse articles online. Also visit the online edition of this
month’s Journal to watch a video of Deputy Editor Daniel S. Pine, M.D.,
present highlights from the issue.
Follow the Journal on Twitter.
E-mail us at email@example.com